Immune Repertoire Sequencing May Be Coming to a Lab Near You
Bradley W. Langhorst, PhD, Chen Song, PhD
The rapidly evolving field of immune sequencing is poised to have a wide-ranging impact to clinical practice
Chen Song, PhD
Chen Song, PhD, is a development scientist at New England Biolabs (NEB) focusing on developing next-generation sequencing workflows for DNA and RNA sequencing in the applications of molecular diagnosis in cancer, infectious disease, and autoimmune disease. Before joining NEB, Chen had 10 years of research experience in assay development for biomarker discovery and therapeutics. Her professional expertise and interest includes molecular diagnostics technology, biomarker discovery and application, and data analysis and visualization.